SCHEMBL14745820

SCHEMBL14745820

CCc1cc(C(=O)Oc2c(CC)c(-c3ccc(OC)cc3)[nH]c(=O)c2C(=O)O)c(=O)[nH]c1-c1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
GSK3B P49841 1/20 0.37
CYP19A1 P11511 2/20 0.35
ANO1 Q5XXA6 1/20 0.35
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
MAPT P10636 3/20 0.35
THRB P10828 1/20 0.35
EDNRB P24530 2/20 0.35
HTT P42858 1/20 0.34
MAPK10 P53779 1/20 0.34
CNR2 P34972 4/20 0.34
POLB P06746 2/20 0.34
HPGD P15428 1/20 0.34
TP53 P04637 1/20 0.33
PLA2G2A P14555 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14745239 0.92 PDE3B (0.43) RXFP1PDE3BPDE3A
SCHEMBL14745819 0.85 GSK3B (0.43) SMN1; SMN2KDM4EALDH1A1GAARXFP1
SCHEMBL14745816 0.81 PDE3B (0.43) ALDH1A1RXFP1PDE3BPDE3AMAPT
SCHEMBL14745499 0.81 PDE3B (0.43) RXFP1PDE3BPDE3ATP53
SCHEMBL14741167 0.78 KDM4E (0.57) SMN1; SMN2KDM4EALDH1A1GAARXFP1
SCHEMBL14741114 0.75 SERPINE1 (0.42) KDM4EGAAPDE3BPDE3AMAPT
SCHEMBL14745238 0.75 SERPINE1 (0.42) KDM4EGAAPDE3BPDE3A
SCHEMBL14745764 0.74 SERPINE1 (0.31)
SCHEMBL14741120 0.73 KDM4E (0.45) SMN1; SMN2KDM4EALDH1A1GAARXFP1
SCHEMBL14745775 0.71 CDC7 (0.31) PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2750505-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC Therapeutics, Inc. (US) 2014-07-09 EP disclosed
WO-2013033240-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2013-03-07 WO disclosed